Encompass Health Corporation Proceeds from Notes Payable
Encompass Health Corporation (EHC) reported Proceeds from Notes Payable of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2026-02-26
- Encompass Health Corporation proceeds from notes payable for the quarter ending 2025-12-31 was $0.00.
- Encompass Health Corporation proceeds from notes payable for the quarter ending 2024-12-31 was $0.00.
- Encompass Health Corporation proceeds from notes payable for the quarter ending 2024-09-30 was $15.00M.
- Encompass Health Corporation proceeds from notes payable for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Encompass Health Corporation proceeds from notes payable for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Encompass Health Corporation proceeds from notes payable for fiscal 2024 was $15.00M, a 25.00% decline from fiscal 2023.
- Encompass Health Corporation proceeds from notes payable for fiscal 2023 was $20.00M, a 69.49% increase from fiscal 2022.
- Encompass Health Corporation proceeds from notes payable for fiscal 2022 was $11.80M.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $0.00 10-Q · filed 2025-10-31 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $15.00M derived: sum of 2 quarters · filed 2026-02-26 | $15.00M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $15.00M 10-Q · filed 2025-10-31 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-06 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $20.00M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $20.00M 10-Q · filed 2024-11-01 | ||
| 2023-06-30 | $20.00M 10-Q · filed 2024-08-06 | |||
| 2022-12-31 | $11.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $11.80M derived: sum of 2 quarters · filed 2025-02-28 | $11.80M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $0.00 10-Q · filed 2023-11-01 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-04 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-27 | |||
| 2018-12-31 | $13.20M 10-K · filed 2019-02-27 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-02-27 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-27 | |||
| 2015-12-31 | $0.00 10-K · filed 2016-02-25 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $0.00 10-K · filed 2016-02-25 | ||
| 2014-09-30 | $0.00 10-Q · filed 2014-10-28 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $3.80M derived: sum of 2 quarters · filed 2016-02-25 | $15.20M 10-K · filed 2016-02-25 | |
| 2013-09-30 | $3.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $15.20M 10-Q · filed 2014-10-28 | ||
| 2013-06-30 | $11.40M 10-Q · filed 2013-07-30 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $0.00 derived: sum of 2 quarters · filed 2015-03-02 | $0.00 10-K · filed 2015-03-02 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | $0.00 10-Q · filed 2013-10-29 | ||
| 2012-06-30 | $0.00 10-Q · filed 2013-07-30 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |